Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-260-1 | CAS number: 91052-98-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on generations indicated in Effect levels (migrated information)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant (minor exception detailed below), guideline study, available as unpublished report, no restrictions, fully adequate for assessment.
- Justification for type of information:
- Justification for Category/Read-across approach:
See justification document for category approach and read-across to individual UVCB constituents in section 13.2.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS 870.3650
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- GLP deviation: no lot number available of test material
- Limit test:
- no
Test material
- Reference substance name:
- Isobutane
- EC Number:
- 200-857-2
- EC Name:
- Isobutane
- Cas Number:
- 75-28-5
- Molecular formula:
- C4H10
- IUPAC Name:
- isobutane
- Details on test material:
- - Name of test material (as cited in study report): isobutane
- Supplier: MG Industries, 3 Great Valley Parkway, Malvern, Pennsylvania 19355, USA
- Substance type: Industrial gas
- Physical state: colourless gas
- Analytical purity: 99.0% per supplier
- Lot/batch No.: Not available
- Stability under test conditions: 99.00% before study, 99.53% after study
- Storage condition of test material: Ambient
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Species: Albino rats (Outbred) VAF/Plus®, Sprague-Dawley derived (CD®), Crl:CD®(SD)IGS BR
- Source: Charles River Laboratories, Raleigh, North Carolina 27610, USA
- Age at study initiation: Approximately 8 weeks
- Weight at study initiation: Males mean 277 g (range 229-301 g); females mean 194 g (range 171-216 g)
- Fasting period before study: None
- Housing: Individually in stainless steel suspended cages with wire mesh floors and fronts (except for mating period when 1 male and 1 female were housed together)
- Diet: Certified Rodent diet No 5002 (PMI Nutrition International, St Louis, Missouri, USA) ad libitum
- Water: Municipal water ad libitum
- Acclimation period: Approximately 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature: 20- 22°C
- Humidity: 42-63%
- Air changes (per hr): Not reported
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 15 December 2003 To: 6 February 2004
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- other: air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 1000 L glass and stainless steel whole-body exposure chamber
- Method of holding animals in test chamber: housed individually, the placement of animals in the chamber was rotated daily to ensure uniform exposure
- System of generating particulates/aerosols: the test substance was delivered from a single cylinder, through a regulator and two backpressure gauges via a flowmeter into the exposure chambers
- Time to T99: 23 minutes maximum
- Airflow rate: 204 Lpm
- Temperature and humidity in chamber: 21-25°C, 52-59%
- Oxygen level: at least 19%
- Air flow rate: minimum flow rate of 200 L/minute
- Air change rate: final airflow set to provide at least one air change in 5 mins (12 air changes/hour)
- Method of particle size determination: yes; weekly
- Treatment of exhaust air: filtered through a system which consisted of a coarse filter, a HEPA filter and an activated charcoal bed
TEST ATMOSPHERE
- Brief description of analytical method used: Infrared spectrophotometer (IR) 4 times per chamber per day
- Samples taken from breathing zone: yes - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: until evidence of mating was seen, or for two consecutive weeks
- Proof of pregnancy: vaginal plug / sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged (how): individually in plastic "shoebox" cages with bedding
- After the mating period was over, females without evidence of copulation were removed from the mating cages, housed individually and monitored for visible signs of pregnancy with corresponding bodyweight gain.
- Any other deviations from standard protocol: no - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Exposure levels were determined using an infrared spectrophotometer 4 times/chamber/day. The test substance was evenly distributed within each chamber. The mean (± SD) analytical concentrations were 0 ± 0, 930.0 ± 27.8, 3122 ± 83 and 9148 ± 201 ppm
- Duration of treatment / exposure:
- Males for 2 weeks prior to mating and for an additional 28 days (minimum) after mating.
Females for 2 weeks prior to mating and gestation days 0-19. - Frequency of treatment:
- 6 hours/day, 7 days/week
- Details on study schedule:
- Females without evidence of mating that appeared to be pregnant were killed on an estimated gestation day 19.
Females that littered and their offspring were killed on post partum day 4.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 ppm
- Remarks:
- Basis: target concentration
- Dose / conc.:
- 900 ppm
- Remarks:
- Basis: target concentration
- Dose / conc.:
- 3 000 ppm
- Remarks:
- Basis: target concentration
- Dose / conc.:
- 9 000 ppm
- Remarks:
- Basis: target concentration
- Dose / conc.:
- 0 ppm (analytical)
- Dose / conc.:
- 930 ppm (analytical)
- Remarks:
- 930 ± 27.8 ppm
Basis: analytical conc.
- Dose / conc.:
- 3 122 ppm (analytical)
- Remarks:
- 3122 ± 83 ppm
Basis: analytical conc.
- Dose / conc.:
- 9 148 ppm (analytical)
- Remarks:
- 9148 ± 201 ppm
Basis: analytical conc.
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, sham-exposed
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily (mortality and clinical condition)
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: - Time schedule: Male rats were examined prior to randomisation and once weekly throughout the study. Female rats were examined prior to randomisation and once weekly throughout the premating period and on gestation days 0, 7, 14, 20 and lactation days 0 (except if parturition was not completed on the same day), 1 and 4.
BODY WEIGHT: Yes
- Time schedule for examinations: Male rats were weighed at randomisation and then weekly throughout the study. Females were weighed at randomisation, on the first day of exposure and twice weekly until evidence of copulation was observed, on gestation days 0, 7, 14 and 20, and on lactation days 1 and 4. Females were not fasted prior to recording terminal bodyweights.
FOOD CONSUMPTION: Yes
- Time schedule for examinations: Once weekly throughout the premating period. For pregnant or confirmed mated females, food consumption was recorded on gestation days 0-7, 7-14, 14-20 and on lactation days 1-4.
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No - Oestrous cyclicity (parental animals):
- No
- Sperm parameters (parental animals):
- During the microscopic examination of the testes, special emphasis was placed on the stages of spermatogenesis and the histopathology of interstitial testicular cell structure.
- Litter observations:
- Not applicable
- Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals (after a minimum of 28 days post-mating).
- Maternal animals: All surviving animals (28 days post-mating).
GROSS NECROPSY: Yes (all animals).
- Tissues examined: adrenal glands, bone (sternum/femur), bone marrow, brain (medulla/pons, cerebrum and cerebellum), epididymides, heart, kidneys, caecum, colon, rectum, larynx, liver, lungs (with mainstem bronchi), lymph nodes (mesenteric and mediastinal), mammary glands (with adjacent skin), nasopharynx, ovaries (with oviducts), prostate, seminal vesicles, duodenum, ileum, jejunum, spinal cord (cervical, thoracic and lumbar), spleen, stomach, testes, thymus, thyroid with parathyroids, tibial nerve, trachea, urinary bladder, uterus with vagina and all macroscopic lesions and tissue masses.
ORGAN WEIGHTS: Yes. Adrenal glands, brain, epididymides, heart, kidneys, liver, lungs, ovaries, spleen, testes, thymus and uterus with vagina.
HISTOPATHOLOGY: Yes (male and female main study only).
- tissues examined: adrenal glands, bone (sternum/femur), brain (cerebellum, cerebrum and cerebellum), epididymes, heart, kidneys, large intestine (caecum, colon and rectum), liver, lungs (with mainstream bronchi), lymph node (mesenteric), lymph node (mediastinal), mammary glands (with adjacent skin), ovaries (with oviducts), prostate, seminal vesicles, small intestine (duodenum, ileum and jejunum), spinal cord (cervical, thoracic and lumbar), spleen, stomach, testes, thymus, thyroids with parathyroids, tibial nerve, trachea, urinary bladder, uterus with vagina, all macroscopic lesions and tissue masses. - Postmortem examinations (offspring):
- Macroscopic postmortem examinations (external only) were performed on all surviving F1 pups on lactation day 4.
- Statistics:
- Group mean values of parameters for all the exposure groups were compared to the control group mean values at each time interval, using appropriate statistical methods.
- Reproductive indices:
- Male and female mating indices, pregnancy rates, male and female fertility indices, gestation indices and the incidence of dams with no viable pups, were analysed statistically.
- Offspring viability indices:
- Live birth index, litter survival and mean pup survival indices (days 0 and 4) were analysed statistically.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
Reproductive function / performance (P0)
- Reproductive performance:
- effects observed, treatment-related
Details on results (P0)
- There was a low incidence of transient red nasal discharge between test days 8 and 29 in all groups including control.
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
- Almost all mated females were found pregnant and delivered live pups; one each in the 900 and 3000 ppm groups and three in the 9000 ppm group (25%) were not pregnant. None of the differences were statistically significant. The mating index for the male rats was compared to control. Mating and gestation indices for females were comparable to control. Almost all females mated at the first opportunity. There were no treatment-related differences in the other reproductive parameters up to time of parturition, including percentange of females completing delivery and duration of gestation.
- There was a dose-related increase in post-implantation loss (as defined by the difference between the number of live pups born and the number of implantations, including any stillborn pups) in 9000 ppm females. Otherwise, there were no treatment-related differences in other parturition parameters including pre-implantation loss, the total number of pups delivered, the number of pups dying, the viability (day 4 survival) index, the pup sex ratio and the number of live pups per litter, compared to control. There were no microscopic findings considered to be treatment-related.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEC
- Remarks:
- systemic effects
- Effect level:
- 9 000 other: ppm (21,394 mg/m3)
- Sex:
- male/female
- Basis for effect level:
- other: no treatment-related effects at the highest concentration tested
- Dose descriptor:
- NOAEC
- Remarks:
- Fertility
- Effect level:
- 3 000 other: ppm (7131 mg/m3)
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
- Dose descriptor:
- NOAEC
- Remarks:
- Reproductive endpoints
- Effect level:
- 3 000 other: ppm (7131 mg/m3)
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
Details on results (F1)
Effect levels (F1)
- Dose descriptor:
- NOAEC
- Remarks:
- developmental effects
- Generation:
- F1
- Effect level:
- 9 000 other: ppm (21,394 mg/m3)
- Sex:
- male/female
- Basis for effect level:
- other: no treatment-related effects on survival, body weight and development up to postnatal day 4 at the highest concentration tested
Target system / organ toxicity (F1)
- Critical effects observed:
- no
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Table 1. Delivery and litter data for rats exposed to isobutane in this study
|
control |
900 ppm |
3000 ppm |
9000 ppm |
No. Corpora lutea |
16.3 |
15.1 |
14.9 |
16.4 |
No. implantation sites |
14.6 |
14.1 |
13.9 |
15.1 |
Pre-implantation loss (no. corpora lutea minus no. implantation sites) |
1.8 |
1.0 |
1.0 |
1.3 |
No. pups per litter |
13.8 |
13.5 |
13.2 |
13.4 |
Post-implantation loss (no. implantation sites minus no. pups per litter) |
0.8 |
0.6 |
0.7 |
1.8* |
* Statistically significant (P<0.05)
Applicant's summary and conclusion
- Conclusions:
- Isobutane was tested in an OECD Guideline 422 combined repeated-exposure toxicity, reproduction and neurotoxicity screen. There was no systemic toxicity, no effects on mating, gestation indices and no effects on pup endpoints. The NOAEC for these endpoints was 9,000 ppm (21,394 mg/m3). Equivocal effects at 9000 ppm on both fertility and increased post-implantation loss led to the NOAEC for fertility and reproductive endpoints being concluded to be 3000 ppm (7131 mg/m3).
- Executive summary:
Rats were exposed to isobutane by inhalation (900, 3000 and 9000 ppm) in an OECD Guideline 422 combined repeated-exposure toxicity study with the reproduction/developmental screening test. Males and females were exposed for 6 hours/day, 7 days/week for 2 weeks prior to mating. Main study females were evaluated for subchronic effects and were exposed for 28 days. A satellite group of females was evaluated for reproductive effects only - exposed for at least two weeks prior to mating initiation, then during mating and gestation (days 0-19). Main study male rats were exposed during the mating and post-mating periods until euthanized for a minimum exposure of 28 days.
Exposure of male and female rats for 4-6 weeks resulted in no general systemic or neurotoxic effects. A NOAEC of 9000 ppm (21,394 mg/m3) was determined for all general systemic/neurotoxic endpoints in this study. The NOAEC for pup endpoints was also 9000 ppm (21,394 mg/m3) based on no effects on survival, body weight and development up to postnatal day 4.
Almost all mated female animals were found pregnant and delivered live pups. In the 9000 ppm group, 25% of the mated females did not become pregnant, and this reduction in the male and fertility indices (75%) was considered to be exposure-related even though it was not statistically significant. The NOAEC for fertility was therefore concluded to be 3000 ppm (7131 mg/m3). This effect is considered to be equivocal - small group sizes (12) were employed in the study and the differences reported between the control and high dose-exposed animals were small. There was also no evidence of a gradation of response, which might have been expected, where some females were not pregnant and others had a reduced number of implantations if this effect had been treatment related. The lower pregnancy rate may therefore have been a chance occurrence. Mating indices for the male rats treated with the isobutane were comparable to controls. Mating and gestation indices for the female rats treated with isobutane were also comparable to controls. There were also no treatment-related differences in the other reproductive parameters up to the time of parturition including the percent of females completing delivery and the duration of gestation, compared to controls. The 75% of females in this study becoming pregnant was also near historical control levels (87.5-100% with a mean of 93.7% in studies conducted between 2001 and 2002).
An exposure-related increase in post-implantation loss was noted for the 9000 ppm group and the NOAEC for reproductive endpoints was also concluded to be 3000 ppm (7131 mg/m3). This effect is also considered to be equivocal. There were no exposure-related differences in any of the parturition parameters including pre-implantation loss, the total number of pups delivered, the number of pups dying, the viability (4 day survival) index, the pup sex ratio and the number of live pups/litter, when compared to control. There were no exposure-related differences in body weights, weight gains or macroscopic differences in the pups at post-natal day 4.The mean number of corpora lutea were similar in both groups whilst the control group was less successful in achieving implantation and therefore had a higher pre-implantation loss than the test group. Both groups give birth to a similar number of pups per litter and therefore the treated group had a higher post-implantation loss than the control group. As both groups had the same potential number of implantations and both gave birth to a similar number of pups there is no indication of any adverse effect of isobutane on embryo/foetal survival. The apparent effect on post-implantation loss is therefore a numerical difference in this calculated parameter whilst the measured parameters showed no effect.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.